Every material Form 8-K Argan filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Argan reported record second-quarter fiscal 2027 results for the three months ended July 31, 2026, with revenue up 61.5% year over year to $384.0 million and net income of $53.3 million, or $3.76 per diluted share, versus $2.50 a year earlier. Project backlog fell to about $2.5 billion from $2.9 billion at January 31, 2026, and the company reported no debt, which may matter to shareholders assessing future revenue visibility.
Q2 revenue rose $146.2 million to $384.0 million; gross margin was 19.3% versus 18.6% a year earlier
Diluted EPS was $3.76 versus $2.50; quarterly cash dividend per share was $0.500 versus $0.375
Project backlog was about $2.5 billion at July 31, 2026, down from $2.9 billion at January 31, 2026
Cash, cash equivalents and investments totaled $1.03 billion, and the company reported no debt
Argan, Inc. reported results for the three months ended April 30, 2026, with revenue up 50.2% year over year to $291.0 million and net income of $46.1 million, or $3.24 per diluted share, versus $1.60 a year earlier. Gross margin rose to 21.0% and the company held $973.6 million in cash, cash equivalents and investments with no debt, though backlog fell to $2.8 billion from $2.9 billion.
Revenue of $291.0 million, up $97.3 million or 50.2% from $193.7 million a year earlier
Net income of $46.1 million, or $3.24 per diluted share, versus $22.6 million, or $1.60, a year earlier
Project backlog of approximately $2.8 billion at April 30, 2026, down from $2.9 billion at January 31, 2026
Quarterly cash dividend of $0.500 per share versus $0.375 a year earlier
Argan reported fourth-quarter fiscal 2026 results for the quarter ended January 31, 2026, with revenue up 12.7% to $262.1 million and net income of $49.2 million, or $3.47 per diluted share, versus $2.22 a year earlier. For the full fiscal year, revenue rose 8.1% to $944.6 million and diluted EPS reached $9.74, compared with $6.15, while project backlog grew to approximately $2.9 billion.
Q4 revenue $262.1 million, up $29.6 million or 12.7% from $232.5 million; gross margin 25.0% vs 20.5%
Q4 net income $49.2 million, or $3.47 per diluted share, vs $31.4 million, or $2.22, a year earlier
Fiscal 2026 net income $137.8 million, or $9.74 per diluted share, vs $85.5 million, or $6.15, in fiscal 2025
Project backlog approximately $2.9 billion at January 31, 2026, vs approximately $1.4 billion a year earlier; the company reported no debt
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Argan filing is on SEC EDGAR ↗. 8-K briefs of other companies →